1.19

4.03% -0.05

After Hours: 1.21 0.02 +1.68%

Creative Medical Technology Holdings Inc (CELZ)

Overview News Price History Financials Discussions Forecast Stock Split

Creative Medical Technology Holdings Inc stock is traded at $1.19, with a volume of 247.61K. It is down -4.03% in the last 24 hours and up +46.88% over the past month. Creative Medical Technology Holdings Inc is a commercial-stage biotechnology company focused on the advancement of regenerative therapies in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics. Its pipeline consists of AlloStem (CELZ-201-DDT); ImmCelz (CELZ-100), a personalized supercharged immune therapy platform; CELZ-201 CREATE-1, an intervention for the treatment of recent onset Type 1 Diabetes; AlloStemSpine for treatment of lower back pain; the Alova program to treat infertility as a result of premature ovarian failure; and other regenerative treatment programs and technologies like OvaStem, CaverStem, FemCelz, StemSpine, and others for the treatment of various indications related to sexual health, spine disc disease, kidney failure, liver failure, etc.

Previous Close:

$1.24

Open:

$1.22

24h Volume:

247.61K

Relative Volume:

0.03

Market Cap:

$7.85M

Revenue:

$3,000

Net Income/Loss:

$-5.76M

P/E Ratio:

-0.6443

EPS:

-1.8471

Net Cash Flow:

$-5.59M

1W Performance:

+6.25%

1M Performance:

+46.88%

6M Performance:

-35.33%

1Y Performance:

-62.34%

1-Day Range:

$1.19

$1.25

1-Week Range:

$1.08

$1.43

52-Week Range:

$0.62

$6.25

Creative Medical Technology Holdings Inc Stock (CELZ) Company Profile

Name

Creative Medical Technology Holdings Inc

Sector

Healthcare (1084)

Industry

Biotechnology (609)

Phone

480-399-2822

Address

211 E. OSBORN RD., PHOENIX

Employee

Twitter

Next Earnings Date

2026-08-14

Latest SEC Filings

CELZ's Discussions on Twitter

Compare CELZ vs VRTX, REGN, ARGX, MRNA, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CELZ Creative Medical Technology Holdings Inc	1.19	8.44M	3,000	-5.76M	-5.59M	-1.8471
VRTX Vertex Pharmaceuticals Inc	547.29	136.93B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	814.79	85.11B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,047.10	64.95B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	149.66	53.23B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	215.44	45.38B	742.00K	-1.37B	-1.07B	-7.0731

Creative Medical Technology Holdings Inc Stock (CELZ) Latest News

Aug 21, 2026

These Three Stocks Fell More Than 10% Today To Hit 52-Week Lows -- What's Driving The Investor Skepticism? - Stocktwits

Aug 21, 2026

Aug 20, 2026

CELZ Looks 171.4% Overvalued on GF Value™ - GuruFocus

Aug 20, 2026

CELZ Looks 142.9% Overvalued on GF Value™ - GuruFocus

Aug 20, 2026

Creative Medical completes enrollment in chronic back pain trial - Investing.com

Aug 20, 2026

Creative Medical Technology Holdings Completes Enrollment And Treatment In FDA-Cleared ADAPT Clinical Trial Evaluating CELZ-201 / Olastrocel - marketscreener.com

Aug 20, 2026

symbol__ Stock Quote Price and Forecast - CNN

Aug 20, 2026

Aug 18, 2026

Creative (CELZ) EPS and Revenue Review: The EPS Result Is Below Expectation on the Day; Market Follow-Through: The Share Price Sheds 1.82% on the DayGuidance Accuracy Score - vinanet.vn

Aug 18, 2026

Aug 14, 2026

CELZ Q2 2026 Earnings: EPS Miss of -$0.41 Reflects Pre-Revenue Pipeline InvestmentCFO Commentary Report - Vinanet

Aug 14, 2026

Aug 11, 2026

Why Avalon Holdings Shares Are Trading Higher By More Than 10%; Here Are 20 Stocks Moving Premarket - Sahm

Aug 11, 2026

CELZ Q2 2026 Earnings: EPS Misses by 3.07% as Pre-Revenue Losses Persist; Stock Climbs 8.75%Cash Flow Report - vinanet.vn

Aug 11, 2026

Aug 10, 2026